Fidelity MSCI Health Care Index ETF -- Insider Buying Index Registering 19.3%

Group 1 - The Fidelity MSCI Health Care Index ETF (FHLC) has 19.3% of its weighted holdings experiencing insider buying in the past six months [1] - Illumina Inc (ILMN) constitutes 0.27% of FHLC, with recent insider purchases from two directors and officers totaling $6,511,021 in value [2] - Ligand Pharmaceuticals Inc (LGND) is the 115 largest holding in FHLC, with insider buying activity from two directors and officers, representing approximately 0.06% of the ETF's total assets [2][3] Group 2 - Recent insider buying at Illumina includes purchases by CFO Ankur Dhingra (6,100 shares at $81.21) and CEO Jacob Thaysen (12,350 shares at $80.86) [2] - Recent insider buying at Ligand Pharmaceuticals includes purchases by CEO Todd C. Davis (9,510 shares at $105.20) and CFO Octavio Espinoza (1,500 shares at $104.06) [3]